Ypsomed Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Ypsomed Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ypsomed Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ypsomed Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Ypsomed Holding AG (Ypsomed) designs, develops and manufactures injection and infusion systems for self-medication used in the treatment of diabetes, growth disorders, infertility, and other clinical indications. The company also provides final assembly services, packaging and labeling equipment, device testing equipment, and services related to human factors, regulatory, intellectual property, testing and design verification, quality, and sustainability.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company conducts research and development (R&D) activities to develop innovative products and enhance the existing product range. Ypsomed’s R&D evaluates innovative approaches and technologies in drug delivery and diabetes care areas and strives to integrate them into its product portfolio. The company is committed to improving and adapting existing products, developing new technologies, and providing additional services for active therapy support. This includes offering networked devices for self-medication, smartphone-based therapy management for diabetes treatment, and expanding digital solutions for successful therapies. As of March 2025, the company had 442 employees serving in the R&D division. The company received 23 first application patents and 35 patents related to invention disclosures in the year ending on March 31, 2025. In FY2025, the company spent CHF33.5 million on its R&D activities, which as a percentage of revenue stood at 4.5% and grew 10.1% YoY.
Business Segments
Overview
Includes operations related to the subsidiary of the company, Ypsotec and management of properties that are not in use for operational purposes.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
- Offers pens and autoinjectors designed for administering liquid medications along with its Digital Health solutions. - Also provides services that include design and development projects, flexible prototyping, human factors engineering, IP landscape management, contract manufacturing, and assembly infrastructure and registration support.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
- Offers various products and services for the self-treatment of diabetes. - Some major products include infusion systems such as insulin pumps, insulin patch pumps, infusion sets and glucose monitoring systems. - Sells products directly to doctors, pharmacies, hospitals and patients through a network of subsidiaries and distributors across the world under the umbrella brand of mylife Diabetescare.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer